Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota

被引:0
|
作者
Hanyan Luo
Hongwei Wu
Lixia Wang
Shuiming Xiao
Yaqi Lu
Cong Liu
Xiankuo Yu
Xiao Zhang
Zhuju Wang
Liying Tang
机构
[1] Institute of Chinese Materia Medica,
[2] China Academy of Chinese Medical Science,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cassiae Semen (CS), the seeds of Cassia obtusifolia L. and C. tora L, have a long medicinal history in China, with suggestions for it to relieve constipation and exert hepatoprotective effects. However, the underlying mechanisms are still unclear. In this study, mice with high-fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) were used to study the hepatoprotective effects of CS. The relationship between gut microbiota and hepatoprotective effect mechanisms mediated by CS extracts, the total aglycone extracts of CS, rubrofusarin-6-β-gentiobioside, and aurantio-obtusin were examined. Our data indicate that CS extracts and components confer a protective effect by ameliorating lipid accumulation, intestinal barrier damage, liver damage, and inflammation on HFD-induced liver injury. Meanwhile, fecal microbe transplantation exerted the pharmacological effect of CS on HFD-fed mice; however, the efficacy of CS was inhibited or eliminated by antibiotic-induced dysbiosis. In conclusion, the therapeutic effects of CS on NAFLD were closely related to the gut microbiota, suggesting a role for TCM in treating disease.
引用
收藏
相关论文
共 50 条
  • [1] Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota
    Luo, Hanyan
    Wu, Hongwei
    Wang, Lixia
    Xiao, Shuiming
    Lu, Yaqi
    Liu, Cong
    Yu, Xiankuo
    Zhang, Xiao
    Wang, Zhuju
    Tang, Liying
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [2] Gut microbiota and non-alcoholic fatty liver disease
    Gkolfakis, Paraskevas
    Dimitriadis, George
    Triantafyllou, Konstantinos
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (06) : 572 - 581
  • [3] Gut microbiota and non-alcoholic fatty liver disease
    Abenavoli, Ludovico
    Procopio, Anna C.
    Scarpellini, Emidio
    Polimeni, Natale
    Aquila, Isabella
    Larussa, Tiziana
    Boccuto, Luigi
    Luzza, Francesco
    MINERVA GASTROENTEROLOGY, 2021, 67 (04): : 339 - 347
  • [4] Gut microbiota and non-alcoholic fatty liver disease
    Paraskevas Gkolfakis
    George Dimitriadis
    Konstantinos Triantafyllou
    Hepatobiliary & Pancreatic Diseases International, 2015, 14 (06) : 572 - 581
  • [5] THE PATHOLOGICAL PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE CORRELATES WITH GUT MICROBIOTA COMPOSITION IN MICE: FROM NON-ALCOHOLIC FATTY LIVER TO NON-ALCOHOLIC STEATOHEPATITIS
    Peng, J.
    Huang, F.
    Li, X.
    Chen, L.
    Feng, Q.
    Hu, Y.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S155 - S157
  • [6] Non-alcoholic fatty liver and the gut microbiota
    Bashiardes, Stavros
    Shapiro, Hagit
    Rozin, Shachar
    Shibolet, Oren
    Elinav, Eran
    MOLECULAR METABOLISM, 2016, 5 (09): : 782 - 794
  • [7] Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease
    Koukias, Nikolaos
    Buzzetti, Elena
    Tsochatzis, Emmanuel A.
    MINERVA ENDOCRINOLOGICA, 2017, 42 (02) : 184 - 194
  • [8] Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease
    Yang, Yao-Jong
    Ni, Yen-Hsuan
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 : S55 - S61
  • [9] Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
    Zhou, Jin
    Tripathi, Madhulika
    Sinha, Rohit A.
    Singh, Brijesh Kumar
    Yen, Paul M.
    HEPATOMA RESEARCH, 2021, 7
  • [10] Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease
    Shen, Feng
    Zheng, Rui-Dan
    Sun, Xing-Qiang
    Ding, Wen-Jin
    Wang, Xiao-Ying
    Fan, Jian-Gao
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2017, 16 (04) : 375 - 381